← All stocks

RIGEL PHARMACEUTICALS INC

RIGL No buying or selling
CIK 0001034842 #2685 in the set updated 20 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

12 insiders · 4 transactions
12.1×

Raul R. Rodriguez holds 12.1 times base salary in stock. $9.57M of shares against $787.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Raul R. Rodriguez last reported holding, valued at $35.00, the price Common Stock was last bought or sold at on the open market here, on 22 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RODRIGUEZ RAUL R
CEO, President
273,362
1.46%
$9.57M
+35.4%
Schorno Dean L
EVP & Chief Financial Officer
82,962
0.4441%
$2.90M
+93.9%
Santos David A
EVP, Chief Commercial Officer
61,622
0.3299%
$2.16M
+64.7%
Furey Raymond J.
EVP, GC, CCO & Corp Sec
50,559
0.2707%
$1.77M
+116.1%
HANNAH ALISON L.
EVP, Chief Medical Officer
35,025
0.1875%
$1.23M
+1,375%
Rojkjaer Lisa
EVP, Chief Medical Officer
34,003
0.1820%
$1.19M
MOOS WALTER H
Director
18,472
0.0989%
$646.52K
+80.7%
Wasman Jane
Director
18,250
0.0977%
$638.75K
+82.5%
LAPOINTE ANTHONY GREGG
Director
18,250
0.0977%
$638.75K
+82.5%
Ali-Jackson Kamil
Director
10,125
0.0542%
$354.38K
+47.3%
Frohlich Mark W
Director
7,000
0.0375%
$245.00K
MILLER MICHAEL PATRICK
Director
5,937
0.0318%
$207.80K
+3,075%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 9,703
History held since 1 Sep 2016